Enanta Pharmaceuticals Stock Price Patterns

ENTA Stock  USD 12.90  0.25  1.98%   
At this time, the RSI of Enanta Pharmaceuticals' share price is approaching 43 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Enanta Pharmaceuticals, making its price go up or down.

Momentum 43

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of Enanta Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Enanta Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Enanta Pharmaceuticals' stock price prediction:
Quarterly Earnings Growth
(0.66)
EPS Estimate Next Quarter
(1.02)
EPS Estimate Current Year
(3.09)
EPS Estimate Next Year
(2.73)
Wall Street Target Price
19.125
Using Enanta Pharmaceuticals hype-based prediction, you can estimate the value of Enanta Pharmaceuticals from the perspective of Enanta Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Enanta Pharmaceuticals using Enanta Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Enanta using crowd psychology based on the activity and movement of Enanta Pharmaceuticals' stock price.

Enanta Pharmaceuticals Implied Volatility

    
  1.08  
Enanta Pharmaceuticals' implied volatility exposes the market's sentiment of Enanta Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Enanta Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Enanta Pharmaceuticals stock will not fluctuate a lot when Enanta Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Enanta Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Enanta because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Enanta Pharmaceuticals after-hype prediction price

    
  USD 12.97  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Enanta contract

Based on the Rule 16, the options market is currently suggesting that Enanta Pharmaceuticals will have an average daily up or down price movement of about 0.0675% per day over the life of the 2026-04-17 option contract. With Enanta Pharmaceuticals trading at USD 12.9, that is roughly USD 0.008708 . If you think that the market is fully incorporating Enanta Pharmaceuticals' daily price movement you should consider acquiring Enanta Pharmaceuticals options at the current volatility level of 1.08%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Enanta Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enanta Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
11.6116.2519.44
Details
Naive
Forecast
LowNextHigh
10.7313.9117.10
Details
6 Analysts
Consensus
LowTargetHigh
17.4019.1221.23
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.27-0.81-0.54
Details

Enanta Pharmaceuticals After-Hype Price Density Analysis

As far as predicting the price of Enanta Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Enanta Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Enanta Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Enanta Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Enanta Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Enanta Pharmaceuticals' historical news coverage. Enanta Pharmaceuticals' after-hype downside and upside margins for the prediction period are 9.78 and 16.16, respectively. We have considered Enanta Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
12.90
12.97
After-hype Price
16.16
Upside
Enanta Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Enanta Pharmaceuticals is based on 3 months time horizon.

Enanta Pharmaceuticals Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Enanta Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enanta Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Enanta Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.34 
3.19
  0.07 
  0.11 
5 Events / Month
8 Events / Month
In about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
12.90
12.97
0.54 
1,450  
Notes

Enanta Pharmaceuticals Hype Timeline

Enanta Pharmaceuticals is currently traded for 12.90. The entity has historical hype elasticity of 0.07, and average elasticity to hype of competition of 0.11. Enanta is anticipated to increase in value after the next headline, with the price projected to jump to 12.97 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.54%, whereas the daily expected return is currently at 0.34%. The volatility of related hype on Enanta Pharmaceuticals is about 975.54%, with the expected price after the next announcement by competition of 13.01. The company reported the previous year's revenue of 65.32 M. Net Loss for the year was (81.89 M) with profit before overhead, payroll, taxes, and interest of 65.32 M. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days.
Check out Enanta Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.

Enanta Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Enanta Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Enanta Pharmaceuticals' future price movements. Getting to know how Enanta Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Enanta Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
PYXSPyxis Oncology(0.02)7 per month 0.00 (0.07) 17.05 (15.41) 70.66 
PRLDPrelude Therapeutics 3.80 26 per month 11.51  0.08  16.44 (16.17) 206.09 
TNYATenaya Therapeutics(0.20)5 per month 0.00 (0.12) 10.57 (11.04) 51.79 
FHTXFoghorn Therapeutics(0.27)10 per month 4.21  0.11  9.16 (5.56) 31.12 
NAUTNautilus Biotechnology(0.01)9 per month 5.41  0.1  10.66 (12.00) 53.15 
CRBUCaribou Biosciences(0.13)7 per month 0.00 (0.19) 6.86 (6.41) 20.16 
IMRXImmuneering Corp(1.14)8 per month 0.00 (0.01) 8.12 (5.64) 67.18 
VYGRVoyager Therapeutics(0.07)6 per month 0.00 (0.07) 4.58 (5.23) 19.71 
AVIRAtea Pharmaceuticals 0.02 9 per month 3.04  0.09  4.64 (4.43) 17.79 
ASMBAssembly Biosciences 1.29 8 per month 0.00 (0.05) 5.85 (6.65) 18.53 

Enanta Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Enanta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enanta using various technical indicators. When you analyze Enanta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Enanta Pharmaceuticals Predictive Indicators

The successful prediction of Enanta Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Enanta Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Enanta Pharmaceuticals based on analysis of Enanta Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Enanta Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Enanta Pharmaceuticals's related companies.
 2023 2024 2025 2026 (projected)
Interest Debt Per Share11.29.788.89.25
Revenue Per Share3.23.062.763.94

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Complementary Tools for Enanta Stock analysis

When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals